Cuban Abdala vaccine: Effectiveness in preventing severe disease and death from COVID-19 in Havana, Cuba; A cohort study

Cuban Abdala vaccine: Effectiveness in preventing severe disease and death from COVID-19 in Havana, Cuba; A cohort study

Summary: Background: COVID-19 vaccines have proven safe and efficacious in reducing severe illness and death. Cuban protein subunit vaccine Abdala has shown safety, tolerability and efficacy (92·3% [95% CI: 85·7‒95·8]) against SARS-CoV-2 in clinical trials. This study aimed to estimate Abdala'...

Full description

Bibliographic Details
Main Authors: Pedro I. Más-Bermejo, Félix O. Dickinson-Meneses, Kenia Almenares-Rodríguez, Lizet Sánchez-Valdés, Raúl Guinovart-Díaz, María Vidal-Ledo, Enrique Galbán-García, Yadira Olivera-Nodarse, Isabel Morgado-Vega, Santiago Dueñas-Carrera, Merardo Pujol, Francisco Hernández-Bernal, Miladys Limonta-Fernández, Gerardo Guillén-Nieto, Verena L. Muzio-González, Marta Ayala-Ávila
Format: Article
Language:English
Published: Elsevier 2022-12-01
Series:The Lancet Regional Health. Americas
Subjects:
COVID-19
SARS-CoV-2
Vaccines
Effectiveness
Vaccination
Cohort studies
Online Access:http://www.sciencedirect.com/science/article/pii/S2667193X22001831

Internet

http://www.sciencedirect.com/science/article/pii/S2667193X22001831

Similar Items